NEW YORK (GenomeWeb) — Innovate UK has awarded a UK consortium £850,000 ($1.3 million) to validate epigenetic signatures in patients with amyotrophic lateral sclerosis. 

The consortium is led by Oxford BioDynamics and includes Oxford University's Nuffield department of clinical neurosciences and Chronos Therapeutics. The project is worth a total of about £1.3 million, Oxford BioDynamics said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.